| Popis: |
There is considerable complexity in the reimbursement processes, and there are many considerations that can go into reimbursement policies for existing and new products. It is important that those responsible for inventing, developing or marketing new medical devices have an understanding of how their products will be reimbursed, because reimbursement is often critical to market success. Thus, reimbursement should be treated as an input to be addressed repeatedly during the design control procedures of a new medical product, beginning with marketing feasibility in the initial design plan. Reimbursement considerations should be addressed in the regulatory strategy, and in the clinical study planning, since these are the stages at which the foundation of a successful reimbursement plan is laid. |
